Fausto N, Webber E M
Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island 02912.
Crit Rev Eukaryot Gene Expr. 1993;3(2):117-35.
The liver is an excellent tissue for the study of growth regulation because of its ability to regenerate by a process of compensatory growth following surgical resection or toxic injury. Much of the investigation on the mechanisms of hepatic growth has been done in partially hepatectomized animals in vivo and in hepatocytes in primary culture. Almost immediately after partial hepatectomy there are major changes in the binding capacity of transcription activators and in the expression of a relatively large number of genes. Many of the immediate early response gene products are themselves transcription activators and thus can multiply and propagate the initial gene activation process. An important issue in the regulation of liver growth is to identify growth factors that may play a role in hepatocyte replication in vivo. In addition to substances that are adjuvants in the mitogenic response at least three growth factors, EGF, TGF alpha, and HGF, are complete mitogens for hepatocytes in culture and appear to play important roles as stimulators of liver growth. We discuss data that indicate that none of these growth factors seems capable of causing a significant increase in DNA synthesis in quiescent hepatocytes in vivo. In contrast, EGF, TGF alpha, and HGF (both the monomer and the heterodimer) increase DNA synthesis in vivo in hepatocytes that have become "competent" to proliferate. We suggest that the competence process involves the activation of transcription factors and protooncogenes, and that during liver regeneration at least some of these changes precede rather than follow growth factor/ligand signaling. The available data suggest that the three growth factors by themselves may not trigger regeneration in strictly quiescent hepatocytes. There is now extensive evidence from work on TGF alpha in developing and regenerating liver as well as studies with transgenic animals to indicate that the factor may act as a cell cycle progression agent. We suggest that "priming" of hepatocytes after partial hepatectomy might have similarities to the widespread activation of genes observed in response to stimuli such as heat shock, ionic imbalances, and changes in redox potentials, and that TGF alpha and also probably the other growth factors act to make primed cells progress through the cycle and undergo DNA synthesis. TGF beta 1 is a potent antagonist to the mitogenic effects of these growth factors on cultured hepatocytes and could be an important factor for terminating the proliferative response of hepatocytes after partial hepatectomy. Although we have moved closer to finding "on" and "off" switches for regeneration, their precise identities and mechanisms remain elusive.
肝脏是研究生长调节的理想组织,因为它能够在手术切除或毒性损伤后通过代偿性生长过程进行再生。许多关于肝脏生长机制的研究是在体内部分肝切除的动物和原代培养的肝细胞中进行的。部分肝切除后几乎立即,转录激活因子的结合能力以及相当数量基因的表达就会发生重大变化。许多即时早期反应基因产物本身就是转录激活因子,因此可以使初始基因激活过程成倍增加并传播。肝脏生长调节中的一个重要问题是确定可能在体内肝细胞复制中起作用的生长因子。除了作为促有丝分裂反应佐剂的物质外,至少三种生长因子,即表皮生长因子(EGF)、转化生长因子α(TGFα)和肝细胞生长因子(HGF),对培养的肝细胞是完全有丝分裂原,并且似乎作为肝脏生长的刺激因子发挥重要作用。我们讨论的数据表明,这些生长因子似乎都不能使体内静止的肝细胞的DNA合成显著增加。相反,EGF、TGFα和HGF(单体和异二聚体)在体内能使已具备增殖“能力”的肝细胞的DNA合成增加。我们认为,这种能力获得过程涉及转录因子和原癌基因的激活,并且在肝脏再生过程中,至少其中一些变化先于而非跟随生长因子/配体信号传导。现有数据表明,这三种生长因子自身可能不会触发严格静止的肝细胞的再生。目前,在发育和再生肝脏中对TGFα的研究以及转基因动物的研究已有大量证据表明,该因子可能作为细胞周期进展因子发挥作用。我们认为,部分肝切除后肝细胞的“预激活”可能与在热休克、离子失衡和氧化还原电位变化等刺激下观察到的广泛基因激活有相似之处,并且TGFα以及可能其他生长因子的作用是使预激活的细胞通过细胞周期并进行DNA合成。转化生长因子β1(TGFβ1)是这些生长因子对培养肝细胞的促有丝分裂作用的有效拮抗剂,并且可能是终止部分肝切除后肝细胞增殖反应的重要因素。尽管我们在寻找再生的“开启”和“关闭”开关方面已取得了进展,但其确切身份和机制仍然难以捉摸。